Business and Finance

Growth rates will moderate in the US and world

Bills passes House with broad bipartisan support; Senate approval likely

A counterargument to the belief that out-of-pocket expenses originate with insurers or PBMs

Sale comes with multi-year supply agreement

Two Canadian Accucaps facilities join global network of 11 Catalent RP Scherer Softgel locations

Allergan’s big commitment to NJ; U. of Michigan converts pharma facilities to healthcare and education

Upcoming trial could explore the intricacies of ‘alternative fulfillment’ via specialty pharmacies

An Amazon-like model for creating an open market for wholesalers to reach customers

Will employer benefit plans lose their enthusiasm for PBMs?

Revenues and earnings were up for the year; stock jumps 8.8% in the day

McKesson disappoints on Q2 earnings call; stock drops 23%. Update: Cardinal reports more revenue, less profit

Price growth is less than branded growth, but higher than inflation

Company may have erroneously been operating under a generic classification

New company is to be known as QuintilesIMS

Drug dispensing, point of care testing and diagnostics are beneficiaries

Drug Channel’s analysis of Inc. 5000 shows some eye-popping growth

CIS by Deloitte seeks to provide a comprehensive service for revenue management

Mylan CEO sticks to authorized-generic strategy for price relief

Roche could overtake Novartis as the No. 1 global firm by then, says Evaluate Pharma

Pharmacy benefit managers feel some marketplace heat even as they establish new benefit programs

Walgreens-Rite Aid merger is still pending

EpiPen controversy has a new twist: paying lower rebates to state Medicaid programs

Sponsored by TGaS Advisors